2m 2m 2m 2m 2m 2m 2m
Anika Therapeuti (ANIK)
NASDAQ
$14.61+$0.02 (+0.10%)
Price as of Jun 23, 2026 4:10 PM EDT- $188.9MMarket Cap
- 29.92%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Anika Therapeuti (ANIK)
$14.61+$0.02 (+0.10%)
ANIK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.59 | ||
Change | +$0.39 (+2.75%) | ||
Open | $14.13 | ||
High | $14.70 | ||
Low | $14.13 | ||
Previous Close | $14.20 | ||
Volume | 54,838 | ||
30-Day Average Volume | 70,222 | ||
1-Week Change | 2.03% | ||
1-Month Change | -1.95% | ||
1-Year Change | 29.92% | ||
3-Year Change | -45.23% | ||
5-Year Change | -66.49% | ||
Fundamentals | |||
Shares Outstanding | 13.3M | ||
Total Assets | $179.4M | ||
Market Cap | $188.9M | ||
Enterprise Value | $147.9M | ||
Period: QTR TTM FY | |||
Revenue | $29.6M | ||
Net Income | -$5.1M | ||
Free Cash Flow | -$6.3M | ||
EBIT | -$4.8M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $72.6M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 1 | ||
P/E | -38 | ||
PEG | 0 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue